RU2011116949A - METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO ENDOTHELIAL SYNTHESIS OF HUMAN NITROGEN OXIDE - Google Patents

METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO ENDOTHELIAL SYNTHESIS OF HUMAN NITROGEN OXIDE Download PDF

Info

Publication number
RU2011116949A
RU2011116949A RU2011116949/14A RU2011116949A RU2011116949A RU 2011116949 A RU2011116949 A RU 2011116949A RU 2011116949/14 A RU2011116949/14 A RU 2011116949/14A RU 2011116949 A RU2011116949 A RU 2011116949A RU 2011116949 A RU2011116949 A RU 2011116949A
Authority
RU
Russia
Prior art keywords
endothelial
antibodies
solution
correction
nitrogen oxide
Prior art date
Application number
RU2011116949/14A
Other languages
Russian (ru)
Other versions
RU2477529C2 (en
Inventor
Александр Сергеевич Белоус (RU)
Александр Сергеевич Белоус
Михаил Владимирович Покровский (RU)
Михаил Владимирович Покровский
Татьяна Григорьевна Покровская (RU)
Татьяна Григорьевна Покровская
Виктор Сергеевич Белоус (RU)
Виктор Сергеевич Белоус
Анна Александровна Арустамова (RU)
Анна Александровна Арустамова
Олег Сергеевич Гудырев (RU)
Олег Сергеевич Гудырев
Михаил Викторович Корокин (RU)
Михаил Викторович Корокин
Владимир Иванович Якушев (RU)
Владимир Иванович Якушев
Олег Ильич Эпштейн (RU)
Олег Ильич Эпштейн
Светлана Александровна Сергеева (RU)
Светлана Александровна Сергеева
Юлия Александровна Заболотнева (RU)
Юлия Александровна Заболотнева
Original Assignee
Общество с ограниченной ответственностью "Научно-производственная фирма "Материа Медика Холдинг" (RU)
Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Научно-производственная фирма "Материа Медика Холдинг" (RU), Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" filed Critical Общество с ограниченной ответственностью "Научно-производственная фирма "Материа Медика Холдинг" (RU)
Priority to RU2011116949/14A priority Critical patent/RU2477529C2/en
Publication of RU2011116949A publication Critical patent/RU2011116949A/en
Application granted granted Critical
Publication of RU2477529C2 publication Critical patent/RU2477529C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведении антител к эндотелиальной синтазе оксида азота человека, характеризующийся тем, что в эксперименте крысам самцам линии Wistar в течение 28 дней, на фоне внутрибрюшинного введения L-Name в дозе 12,5 мг/кг, ежедневно, 2 раза в сутки по 4,5 мл/кг (9 мл/кг/сут.), внутрижелудочно, вводят смесь растворов гомеопатических разведении поликлональных кроличьих антител к эндотелиальной синтазе оксида азота человека - С12, С30, С200. A method for correcting endothelial dysfunction with a solution of homeopathic dilution of antibodies to human nitric oxide endothelial synthase, characterized in that in the experiment, rats of Wistar males for 28 days, against the background of intraperitoneal administration of L-Name at a dose of 12.5 mg / kg, 2 times daily 4.5 ml / kg (9 ml / kg / day) per day, intragastrically, a mixture of solutions of homeopathic dilution of polyclonal rabbit antibodies to human nitric oxide endothelial synthase is administered - C12, C30, C200.

Claims (1)

Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведении антител к эндотелиальной синтазе оксида азота человека, характеризующийся тем, что в эксперименте крысам самцам линии Wistar в течение 28 дней, на фоне внутрибрюшинного введения L-Name в дозе 12,5 мг/кг, ежедневно, 2 раза в сутки по 4,5 мл/кг (9 мл/кг/сут.), внутрижелудочно, вводят смесь растворов гомеопатических разведении поликлональных кроличьих антител к эндотелиальной синтазе оксида азота человека - С12, С30, С200. A method for correcting endothelial dysfunction with a solution of homeopathic dilution of antibodies to human nitric oxide endothelial synthase, characterized in that in the experiment, rats of Wistar males for 28 days, against the background of intraperitoneal administration of L-Name at a dose of 12.5 mg / kg, 2 times daily 4.5 ml / kg (9 ml / kg / day) per day, intragastrically, a mixture of solutions of homeopathic dilution of polyclonal rabbit antibodies to human nitric oxide endothelial synthase is administered - C12, C30, C200.
RU2011116949/14A 2011-04-28 2011-04-28 Method for endothelial dysfunction correction by solution of homoeopathic dilutions of human endothelial nitrogen oxide synthase antibodies RU2477529C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011116949/14A RU2477529C2 (en) 2011-04-28 2011-04-28 Method for endothelial dysfunction correction by solution of homoeopathic dilutions of human endothelial nitrogen oxide synthase antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011116949/14A RU2477529C2 (en) 2011-04-28 2011-04-28 Method for endothelial dysfunction correction by solution of homoeopathic dilutions of human endothelial nitrogen oxide synthase antibodies

Publications (2)

Publication Number Publication Date
RU2011116949A true RU2011116949A (en) 2012-11-10
RU2477529C2 RU2477529C2 (en) 2013-03-10

Family

ID=47321875

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011116949/14A RU2477529C2 (en) 2011-04-28 2011-04-28 Method for endothelial dysfunction correction by solution of homoeopathic dilutions of human endothelial nitrogen oxide synthase antibodies

Country Status (1)

Country Link
RU (1) RU2477529C2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
UA76639C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
RU2306953C1 (en) * 2006-07-14 2007-09-27 Михаил Владимирович Покровский Method for correction of endothelial dysfunction with solvent mixture of homeopathic dilutions of polyclonal rabbit antibodies to human endothelial nitrogen oxide synthase c12, c30, c200
RU2343927C1 (en) * 2007-09-13 2009-01-20 Михаил Владимирович Покровский Method of correction of endothelial dysfunction using lozartan in complex with admixture of solutions of homeopathic delutions of polyclonal rabbit antibodies to endothelial synthase of human nitrogen oxide-c12, c30, c200
RU2402824C1 (en) * 2009-07-21 2010-10-27 Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию Method of modelling chronic toxic cardiopathy

Also Published As

Publication number Publication date
RU2477529C2 (en) 2013-03-10

Similar Documents

Publication Publication Date Title
CY1124882T1 (en) 1,4-DI-CONSTITUTED PYRIDAZINE ANALOGUES AND METHODS FOR THERAPEUTIC TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY
PH12017501426A1 (en) Derivatives of betulin
PE20190262A1 (en) METHODS FOR TREATING CANCER BY USE OF PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS
EA201690287A1 (en) 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY
PE20142167A1 (en) ANTI-LGR5 ANTIBODIES AND IMMUNOCONJUGATES
EA201391000A1 (en) INDOL CONNECTIONS OR THEIR ANALOGUES USEFUL FOR THE TREATMENT OF AGE MAKULAR DEGENERATION (AMD)
EA201690247A1 (en) AMINOMETHYBYRIL DERIVATIVES-INHIBITORS OF COMPLEX D FACTOR AND USE
TN2016000210A1 (en) Urea derivative or pharmacologically acceptable salt thereof.
EA201391525A1 (en) GLYCOSIDE DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DIABETES
WO2011159903A3 (en) Asenapine maleate
EA201492023A1 (en) REGULATORS OF THE COMPLEX WAY AND THEIR APPLICATION
PH12015501752A1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
JP2013535483A5 (en)
WO2012148148A3 (en) Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
RU2011116949A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO ENDOTHELIAL SYNTHESIS OF HUMAN NITROGEN OXIDE
RU2008110101A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY PHOSPHOGLIV LYOPHYLIZATE WITH L-NAME INDUCED NITROGEN OXIDE DEFICIENCY
RU2011116946A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO INTERLEUKIN-1
RU2011116943A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO ENDOTHELIAL SYNTHESIS OF HUMAN NITROGEN OXIDE IN A COMPLEX WITH A SOLUTION OF HOMEOPATHIC DISEASES OF ANTITZE OF THE ANTITZE OF THE ANTITZE OF THE ANTITZE OF THE ANTITZE OF THE ANTITZE
RU2010144193A (en) METHOD FOR CORRECTION OF DISTURBANCES OF MICROCIRCULATION IN THE PLACENTA AT ADMA-LIKE MODEL OF HESTOSIS
RU2011116948A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODY HOMEOPATHIC DILUTION SOLUTION TO THE VASCULAR ENDOTHELIUM GROWTH FACTOR
RU2011116945A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY AN ANTIBODIES HOMEOPATHIC DILUTION TO TUMOR-ALPHA NECROSIS FACTOR
RU2012104984A (en) METHOD FOR PHARMACOLOGICAL CORRECTION OF SKELETAL ISCHEMIA ISCHEMIA SILDENAFIL, INCLUDING L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY
RU2011116944A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO INTERLEUKIN-6
RU2011116947A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMEOPATHIC DILUTIONS OF ANTIBODIES TO THE C-END Fragment of the Angiotensin II Receptor
RU2012121242A (en) METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF THE SKELETAL MUSCLE BY NICORANDIL

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20150429